Bio Pharma Dive
MAY 14, 2021
The biotech's treatment is part of a wave of new treatments meant to mimic the effects of natural killer cell transplants in leukemia, though analysts remain skeptical.
World of DTC Marketing
MAY 14, 2021
THOUGHT: I love working in the pharma industry. Yes, I have been critical of the industry because I believe there is too much focus on pleasing Wall Street, yet I believe that there are some really good people starting to climb the ladder and that soon we’ll see some really substantial changes. Believe in what we can do together. One change in the workplace is that employees want more of a say about their company when it comes to social and moral issues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Camargo
MAY 10, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA’s Accelerated Approval Program Comes Under Fire. The public’s faith in drugs approved under the FDA’s accelerated approval program is not blind — it relies heavily on the industry’s follow-through on confirmatory trials and the FDA’s subsequent review and final approval.
BioSpace
MAY 10, 2021
The CDC says that COVID-19 is an airborne threat, stating that transmission and subsequent infection can occur via inhalation of very fine respiratory droplets and aerosolized particles.
Bio Pharma Dive
MAY 10, 2021
Laronde comes equipped with $50 million in funding from Flagship Pioneering and a goal to upend how diseases are treated with long-lasting RNA medicines.
World of DTC Marketing
MAY 11, 2021
IN SUMMARY: Hypertension, diabetes, and obesity drive a lot of healthcare costs, and the obesity epidemic may be one of the root causes of the rise in rates of hypertension, diabetes and even certain types of cancer. As the oldest millennials start to hit 40, many are finding themselves coping with chronic health conditions — more so than previous generations, according to some recent research and it’s going to lead to higher healthcare costs for ALL of us.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
MAY 14, 2021
Cellino’s unique blend of lasers and machine learning is transforming the manufacture of autologous stem cell therapies from an inconsistent hand-crafted endeavor to a scalable, efficient, closed-loop, modern process.
Bio Pharma Dive
MAY 10, 2021
The emergency clearance greatly expands the pool of people who can be vaccinated in the U.S. just as some states are beginning to report waning demand.
World of DTC Marketing
MAY 13, 2021
QUICK READ: Reaching physicians with key brand messages isn’t hard, but the online landscape has become crowded with many players. By far, Medscape is still number one in physician reach , and medical journal advertising has been proven to result in more branded Rx’s. Deloitte showed there is a significant trust gap between pharmaceutical companies and people working in healthcare.
pharmaphorum
MAY 10, 2021
Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. Dix led the programme from December until he stepped down last week and told the Daily Telegraph that the UK’s vaccination campaign should be enough to protect from the virus and its known variants by the summer.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
MAY 14, 2021
A study, published recently in the New England Journal of Medicine, demonstrated no obvious safety signals among pregnant persons who received the mRNA vaccines.
Bio Pharma Dive
MAY 13, 2021
Study results could address concerns raised by FDA advisers who recently voted against approval of Keytruda in patients with early-stage breast cancer.
World of DTC Marketing
MAY 13, 2021
It’s 2021. Trends are a whole lot different from what they were a decade ago. This doesn’t just relate to fashion or hobby choices, either. It’s also highly relevant in the marketing world. One of the most essential methods to generate organic traffic is content marketing when it comes to marketing. With the right content marketing strategy in place, a website has the ability to do that all-important climb to the first page of Google.
pharmaphorum
MAY 10, 2021
A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty shot. . The Pharmacovigilance Risk Assessment Committee (PRAC) says it is aware of cases of myocarditis and pericarditis – inflammation of the heart muscle and membrane around the heart – with the vaccine.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
MAY 9, 2021
Over the past year, the world at large has become more familiar with mRNA technology thanks to vaccines developed against COVID-19. Now the world will be introduced to a new type of RNA-based medicine called Endless RNA, or eRNA for short.
Bio Pharma Dive
MAY 13, 2021
The San Diego-based biotech's drug, which will now be sold as Zynrelef, had perviously been rejected by the agency in 2019 and 2020.
BioPharma Reporter
MAY 14, 2021
Moderna has agreed to provide 15m doses of its updated variant COVID-19 vaccine to Australia, providing a boost to its efforts to generate ongoing revenues from its coronavirus work.
pharmaphorum
MAY 11, 2021
Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX. Healthcare systems the world over have been facing the same challenges for some time – and the pandemic has only served to compound them. Aging populations, a growing number of people living with long-term conditions, and dwindling resources meant the NHS was already being asked to do more with less before COVID-19 hit.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
BioSpace
MAY 12, 2021
Staying at home during the COVID-19 pandemic actually increased the spread of infection, according to new study published by the University of Chicago and, soon, by the National Bureau of Economic Research.
Bio Pharma Dive
MAY 10, 2021
Tezepelumab is one of Amgen's top experimental medicines and a U.S. OK would help its efforts to offset revenue declines from its aging blockbusters.
Pharma Times
MAY 10, 2021
Researchers are initiating clinical trials to evaluate whether targeting the CD38 pathway can provide benefit for people with prostate cancer
pharmaphorum
MAY 12, 2021
Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the patent thicket surrounding Humira, a common ploy in pharma that seems to be particularly effective in the US. Several biological drugs have remained unchallenged on the US market thanks to a legal force-field from supplementary patents, after the main patent has expired and after protection has lapsed in Europe and other cou
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
MAY 12, 2021
At the Seraph Research Institute, scientists presented new research at the 2021 ASGCT that shows promise in treating HIV.
Bio Pharma Dive
MAY 10, 2021
A strategy needs to be put in place to profile patients and then form profile-specific strategies to accelerate diagnosis through HCP outreach, education, etc.
XTalks
MAY 13, 2021
Given that people have spent most of the past year being locked down at home due to the COVID-19 pandemic, it comes as no surprise that much of that time has been spent binging content on TV and through digital streaming services. In light of this, pharma wasted no time throwing some added cash towards TV ads. Taking advantage of the opportunity, the top ten pharma brands spent 17 percent more on TV ads in April 2020 compared to just a month prior, raising their monthly ad expenditures from $156
pharmaphorum
MAY 13, 2021
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Over the 12 months to December 2020 the number of global Veeva CRM Engage Meetings increased sixfold, while those held in Europe saw an eight-fold increase – with 200,000 remote meetings conducted in Europe in November alone.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
MAY 13, 2021
The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and currently have more than 160 rare disease programs in the works.
Bio Pharma Dive
MAY 11, 2021
Bellco Capital, led by Kite Pharma and Allogene Therapeutics founder Arie Belldegrun, will co-sponsor the transaction alongside Eagle Equity Partners.
Pharma Times
MAY 10, 2021
New data presented at the 2021 European Society of Medical Oncology (ESMO) Breast Cancer virtual congress
pharmaphorum
MAY 10, 2021
As lockdown gradually eases, things are starting to look up but the lasting impact COVID-19 has had on our wellbeing remains. During Mental Health Awareness Month we look at the mental health stigma amongst men. To say we’re in the midst of a mental health crisis is not an exaggeration. Mental health concerns have been increasing for years and have only been amplified by the COVID-19 crisis and national lockdowns.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
355 
Let's personalize your content